However, despite this decline, ongoing challenges continue to burden healthcare providers.
Here are other key points from the report:
- Manufacturing delays caused by the aftermath of Hurricane Helene resulted in 12 new product shortages, including critical and life-saving fluids.
- Almost half, or 48%, of the active drug shortages began in 2022 or earlier, highlighting the long-term nature of the crisis.
- Managing the shortages requires significant adjustments to pharmacy automation and electronic health record systems, further straining pharmacy staff who are already dealing with staffing shortages.
- Injectable drugs remain a significant portion of the active shortages, affecting a wide range of treatments, according to the report.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.